To judge whether an Amplatzer™ Septal Occluder can be used as standard therapy instead
of surgery for closure of atrial septal defects we report our experiences in 200 patients. Of …

Objective Transcatheter closure of atrial septal defects (ASDs) is currently a reliable
alternative to surgery, even though challenging in the case of complex septal anatomy. The …

To judge whether an Amplatzer Septal Occluder (ASO) can be used as a safe therapy
instead of surgery for closure of large atrial septal defects> 25 mm in diameter, we report our …

Objectives. This study reports our clinical experience with transcatheter closure of secundum
atrial septal defects (ASDs) in children, using the Amplatzer, a new occlusion device …

Forty patients were catheterized for closure of atrial septal defects with the Rashkind patent
ductus arteriosus umbrella device, a modified Rashkind umbrella device, and the newly …

Objectives: Occlutech Figulla ASD Occluder (FSO) is an alternative device to Amplatzer
Septal Occluder (ASO) with some structural innovations including increased flexibility …

Atrial septal defect (ASD) is one of the most common congenital heart defects, accounting for
7%-10% of all congenital heart disease (CHD) in children and 30%-33% of defects …

Resultados. Se aceptó para cierre percutáneo a 181 pacientes (87%). Se rechazaron 28
casos, en su gran mayoría por el excesivo tamaño del defecto. En 172 pacientes con CIA se …

Methods Between September 1999 and March 2007, a total of 41 patients (24 females and
17 males) who were> 60 years of age (range 62-87.2 years) and had indications for ASD …

The first attempt at transcatheter closure of an atrial septal defect (ASD) was reported in
1976. 1 Since then, few devices have been evaluated in children and adults with variable …